BIOMAT Database Logo BIOMAT Database Logo

Biguanides. 1978

M Nattrass, and K G Alberti

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D007773 Lactates Salts or esters of LACTIC ACID containing the general formula CH3CHOHCOOR.
D008687 Metformin A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289) Dimethylguanylguanidine,Dimethylbiguanidine,Glucophage,Metformin HCl,Metformin Hydrochloride,HCl, Metformin,Hydrochloride, Metformin
D010629 Phenformin A biguanide hypoglycemic agent with actions and uses similar to those of METFORMIN. Although it is generally considered to be associated with an unacceptably high incidence of lactic acidosis, often fatal, it is still available in some countries. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290) Fenformin,Phenylethylbiguanide
D002026 Buformin An oral hypoglycemic agent that inhibits gluconeogenesis, increases glycolysis, and decreases glucose oxidation. Butylbiguanide,1-Butylbiguanide,Adebit,Gliporal,Silubin,Silubin Retard,1 Butylbiguanide,Retard, Silubin
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001645 Biguanides Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES. Biguanide

Related Publications

M Nattrass, and K G Alberti
[Biguanides].
December 2006, Nihon rinsho. Japanese journal of clinical medicine,
M Nattrass, and K G Alberti
[Biguanides].
September 1978, Deutsche medizinische Wochenschrift (1946),
M Nattrass, and K G Alberti
[Biguanides].
January 2011, Nihon rinsho. Japanese journal of clinical medicine,
M Nattrass, and K G Alberti
[Antidiabetic biguanides].
January 1969, Journees annuelles de diabetologie de l'Hotel-Dieu,
M Nattrass, and K G Alberti
Biguanides reassessed.
January 1969, Drug and therapeutics bulletin,
M Nattrass, and K G Alberti
[The biguanides].
October 1967, Il Policlinico. Sezione pratica,
M Nattrass, and K G Alberti
[The biguanides].
December 1987, Soins; la revue de reference infirmiere,
M Nattrass, and K G Alberti
[The biguanides].
October 1974, Minerva medica,
M Nattrass, and K G Alberti
Guanidines and biguanides.
January 1980, Pharmacology & therapeutics,
M Nattrass, and K G Alberti
Biguanides and NIDDM.
June 1992, Diabetes care,
Copied contents to your clipboard!